129 related articles for article (PubMed ID: 33352323)
61. Thrombosis and Haemostasis challenges in COVID-19 - Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review.
Mazilu L; Katsiki N; Nikolouzakis TK; Aslanidis MI; Lazopoulos G; Kouretas D; Tsatsakis A; Suceveanu AI; Stoian AP; Parepa IR; Voinea F; Suceveanu AP; Arsene AL; Velescu BȘ; Vesa C; Nitipir C
Food Chem Toxicol; 2021 Feb; 148():111974. PubMed ID: 33421462
[TBL] [Abstract][Full Text] [Related]
62. Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
Daxon BT; Lark E; Matzek LJ; Fields AR; Haselton KJ
A A Pract; 2021 Feb; 15(2):e01376. PubMed ID: 33560642
[TBL] [Abstract][Full Text] [Related]
63. Devil is in the airspace: compartmentalisation of inflammation during COVID ARDS.
Shaver CM
Thorax; 2023 Sep; 78(9):848-849. PubMed ID: 37286237
[No Abstract] [Full Text] [Related]
64. Reader Response: Critical Illness-Associated Cerebral Microbleeds in COVID-19 Acute Respiratory Distress Syndrome.
Edlow BL; Conklin J; Huang SY
Neurology; 2021 Aug; 97(5):254. PubMed ID: 34341081
[No Abstract] [Full Text] [Related]
65. Acute Respiratory Distress Syndrome due to COVID-19 during Pregnancy.
Minors T; Golen T
Neoreviews; 2021 Aug; 22(8):e551-e558. PubMed ID: 34341164
[No Abstract] [Full Text] [Related]
66. Intravenous immunoglobulin therapy for COVID-19 ARDS.
Wilfong EM; Matthay MA
Lancet Respir Med; 2022 Feb; 10(2):123-125. PubMed ID: 34774186
[No Abstract] [Full Text] [Related]
67. Low hemodynamic impact of moderate ARDS caused by SARS-CoV2.
Ioan AM; Gonzalez-Lorenzo O; Kallmeyer Mayor A; Pérez-Calvo C; Santos A
Med Intensiva (Engl Ed); 2023 Jun; 47(6):348-350. PubMed ID: 36931994
[No Abstract] [Full Text] [Related]
68. The monitoring of acute cor pulmonale is still necessary in "Berlin" ARDS patients.
Chiumello D; Pesenti A
Intensive Care Med; 2013 Oct; 39(10):1864-6. PubMed ID: 23942861
[No Abstract] [Full Text] [Related]
69. Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
de Roquetaillade C; Guillemin J; Beaucoté V; Barthelemy R; Chousterman BG
J Am Coll Cardiol; 2022 Jan; 79(1):e11. PubMed ID: 34991792
[No Abstract] [Full Text] [Related]
70. Letter to the Editor: Pulmonary circulation abnormalities in post-acute COVID-19 syndrome and acute vascular distress syndrome.
Jounieaux V; Rodenstein DO; Mahjoub Y
Eur Radiol; 2024 Jun; 34(6):4189-4190. PubMed ID: 37947838
[No Abstract] [Full Text] [Related]
71. Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'.
Kawada T
Ann Rheum Dis; 2023 Apr; 82(4):e77. PubMed ID: 33504481
[No Abstract] [Full Text] [Related]
72. Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada.
Piantoni S; Andreoli L; Colombo E; Mendeni M; Ghirardelli ML; Brucato A; Imazio M; Furloni R; Franceschini F; Airó P; Scarsi M
Ann Rheum Dis; 2023 Apr; 82(4):e78. PubMed ID: 33504480
[No Abstract] [Full Text] [Related]
73. Acute Cor Pulmonale in a Critically Ill Patient with COVID-19 Resolved with Venoarteriovenous Extracorporeal Membrane Oxygenation.
Sauza-Sosa JC; Rojas-Gomez CA; Montes de Oca-Sandoval MA; Hernandez-Rendon E; Lima-Linares R; Camarena-Alejo G
CASE (Phila); 2021 Jun; 5(3):138-142. PubMed ID: 33681542
[TBL] [Abstract][Full Text] [Related]
74. Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19.
Vujaklija Brajković A; Zlopaša O; Gubarev Vrdoljak N; Goran T; Lovrić D; Radonić R
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101678. PubMed ID: 33716189
[No Abstract] [Full Text] [Related]
75. Hydrocortisone rapidly and significantly reduces the IL-6 level in blood and lungs of patients with COVID-19-related ARDS.
Guillon A; Jouan Y; Kassa-Sombo A; Paget C; Dequin PF
Crit Care; 2024 Mar; 28(1):101. PubMed ID: 38549157
[No Abstract] [Full Text] [Related]
76. [Acute
Zapata L; Suárez-Montero JC; Flores-Orella MN; Morales-Alarcón EM; Segarra A; Santos-Rodríguez JA
Med Intensiva; 2022 Nov; 46(11):645-647. PubMed ID: 35079192
[No Abstract] [Full Text] [Related]
77. Etiopathogenetic Particularities and Prognostic Impact of Right Ventricular Involvement in COVID-19-Related Acute Respiratory Distress Syndrome.
Dandel M
Crit Care Med; 2022 Apr; 50(4):e396-e397. PubMed ID: 34964569
[No Abstract] [Full Text] [Related]
78. Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era.
Gandini L; Fior G; Schibler A; Obonyo NG; Li Bassi G; Suen JY; Fraser JF
Crit Care; 2023 Mar; 27(1):124. PubMed ID: 36966340
[No Abstract] [Full Text] [Related]
79. Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab.
Ostendorf L; Muench F; Thormählen L; Galbavý Z; Körner R; Nee J; Schneider U
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37479497
[No Abstract] [Full Text] [Related]
80. Vitamin D deficiency and cardiac failure in infancy.
Carlton-Conway D; Tulloh R; Wood L; Kanabar D
J R Soc Med; 2004 May; 97(5):238-9. PubMed ID: 15121815
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
